Transmission stage investment of malaria parasites in response to in-host competition.
Conspecific competition occurs in a multitude of organisms, particularly in parasites, where several clones are commonly sharing limited resources inside their host. In theory, increased or decreased transmission investment might maximize parasite fitness in the face of competition, but, to our knowledge, this has not been tested experimentally. We developed and used a clone-specific, stage-specific, quantitative PCR protocol to quantify Plasmodium chabaudi replication and transmission stage densities in mixed-clone infections. We co-infected mice from two strains with an avirulent and virulent parasite clone and found competitive suppression of in-host (blood-stage) parasite densities and generally corresponding reductions in transmission stage production, with the virulent clone obtaining overall competitive superiority. In response to competitive suppression, there was little evidence of any alteration in transmission stage investment, apart from a small reduction by one of the two clones in one of the two host strains. This alteration did not result in a competitive advantage, although it might have reduced the disadvantage. This study supports much of the current literature, which predicts that conspecific in-host competition will result in a competitive advantage and positive selection for virulent clones and thus the evolution of higher virulence.
Wargo
Andrew R
AR
Institutes of Evolution, Immunology and Infection Research, Ashworth Laboratories, School of Biological Sciences, University of Edinburgh, The King's Buildings, West Mains Road, Edinburgh EH9 3JT, UK. awargo@u.washington.edu
de Roode
Jacobus C
JC
Huijben
Silvie
S
Drew
Damien R
DR
Read
Andrew F
AF
D000818:Animals; D005260:Female; D006790:Host-Parasite Interactions; D008288:Malaria / Q000469:parasitology* / Q000635:transmission*; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D016788:Plasmodium chabaudi / Q000235:genetics / Q000502:physiology*
Trans R Soc Trop Med Hyg. 1998 Nov-Dec;92(6):580-5
10326095
Proc Biol Sci. 1999 Apr 7;266(1420):741-8
10331293
Parasitology. 1999 Apr;118 ( Pt 4):339-46
10340323
Exp Parasitol. 1999 Sep;93(1):45-54
10464038
Exp Parasitol. 2000 Jul;95(3):163-9
10964643
Q Rev Biol. 2000 Sep;75(3):261-75
11008699
Mol Biol Evol. 2000 Oct;17(10):1467-82
11018154
J Parasitol. 2000 Oct;86(5):1041-5
11128477
Mol Biochem Parasitol. 2001 Apr 6;113(2):251-60
11295179
Parasitology. 2001 Apr;122(Pt 4):483-9
11315182
Science. 2001 May 11;292(5519):1099-102
11352063
Proc Biol Sci. 2001 Nov 22;268(1483):2325-30
11703872
Mol Biochem Parasitol. 2001 Dec;118(2):147-54
11738705
Nature. 2001 Dec 13;414(6865):751-6
11742400
Parasitology. 2002 Jan;124(Pt 1):31-8
11811801
Philos Trans R Soc Lond B Biol Sci. 2002 Jan 29;357(1417):55-63
11839182
Trends Parasitol. 2001 Nov;17(11):525-31
11872397
Proc Biol Sci. 2002 Apr 22;269(1493):809-15
11958712
J Parasitol. 2002 Feb;88(1):97-101
12053988
Nature. 2002 Aug 15;418(6899):742
12181557
Trends Microbiol. 2002 Sep;10(9):401-5
12217504
Nature. 2002 Oct 3;419(6906):512-9
12368865
Proc Biol Sci. 2003 Jan 22;270(1511):189-93
12590759
Proc Biol Sci. 2003 Jan 7;270(1510):37-44
12590769
J Parasitol. 2003 Feb;89(1):190-2
12659329
Infect Genet Evol. 2002 Jul;1(4):287-96
12798007
Am Nat. 2003 Jul;162(1):122-33
12856241
Proc Biol Sci. 1992 Dec 22;250(1329):249-56
1362993
Exp Parasitol. 1964 Jun;15:213-25
14191322
Parasitology. 2003 Nov;127(Pt 5):411-8
14653530
Parasitol Today. 1997 Jul;13(7):262-7
15275063
Parasitol Today. 1997 Apr;13(4):135-40
15275099
Mol Biochem Parasitol. 2004 Sep;137(1):35-41
15279949
BMC Evol Biol. 2004 Sep 08;4:30
15355551
Malar J. 2004 Sep 14;3:33
15367331
Trends Parasitol. 2004 Dec;20(12):575-80
15522667
Science. 2005 Jan 7;307(5706):82-6
15637271
Proc Biol Sci. 2005 Mar 7;272(1562):511-7
15799947
Proc Natl Acad Sci U S A. 2005 May 24;102(21):7624-8
15894623
Cell. 2005 Jun 3;121(5):675-87
15935755
Drug Resist Updat. 2005 Feb-Apr;8(1-2):43-50
15939341
J Evol Biol. 2005 Jul;18(4):911-21
16033563
Am Nat. 2005 Nov;166(5):531-42
16224719
Exp Parasitol. 2006 Jan;112(1):13-20
16256988
Trans R Soc Trop Med Hyg. 2006 Feb;100(2):176-83
16257026
Theor Popul Biol. 2006 May;69(3):323-31
16469343
Trends Parasitol. 2006 Sep;22(9):424-30
16846756
Am Nat. 2006 Jul;168(1):41-53
16874614
Evolution. 2006 Jul;60(7):1358-71
16929653
Evolution. 1999 Jun;53(3):689-703
28565637
J Theor Biol. 1983 Feb 7;100(3):411-26
6834864
Mol Biochem Parasitol. 1994 Dec;68(2):285-96
7739674
Parasitology. 1995 Feb;110 ( Pt 2):115-22
7885729
Mol Biochem Parasitol. 1994 May;65(1):11-22
7935618
Infect Immun. 1994 Sep;62(9):3761-5
8063391
Proc Biol Sci. 1994 Jan 22;255(1342):81-9
8153140
Parasitology. 1994 Feb;108 ( Pt 2):129-37
8159458
Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):985-9
8577773
Am J Trop Med Hyg. 1996 Jan;54(1):18-26
8651363
Parasitology. 1996 Jul;113 ( Pt 1):25-38
8710412
Q Rev Biol. 1996 Mar;71(1):37-78
8919665
J Parasitol. 1996 Dec;82(6):900-6
8973397
Int J Parasitol. 1996 Oct;26(10):1095-101
8982790
Proc Biol Sci. 1997 Apr 22;264(1381):553-9
9149425
Parasite Immunol. 1996 Apr;18(4):173-80
9223172
Mol Biochem Parasitol. 1997 Nov;89(2):235-44
9364968
J Clin Invest. 1998 May 1;101(9):2008-16
9576766
Int J Parasitol. 1998 May;28(5):719-25
9650051
Mol Biochem Parasitol. 1998 Jun 1;93(2):285-94
9662712
Science. 1998 Nov 20;282(5393):1432-5
9822369
J Theor Biol. 1998 Dec 7;195(3):293-313
9826485
Mol Cell Biol. 1999 Feb;19(2):967-78
9891033